Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126578621 | 12657862 | 1 | I | 20160813 | 20160816 | 20160816 | EXP | PL-JNJFOC-20160812420 | JANSSEN | 0.00 | M | Y | 0.00000 | 20160816 | CN | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126578621 | 12657862 | 1 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
| 126578621 | 12657862 | 2 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | TWO PACKAGE OF RISPERIDONE | U | U | 20272 | TABLETS | |||||||
| 126578621 | 12657862 | 3 | SS | CHLORPROTHIXENE | CHLORPROTHIXENE | 1 | Unknown | 1 PACKAGE OF CHLORPROTHEXENE | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126578621 | 12657862 | 1 | Product used for unknown indication |
| 126578621 | 12657862 | 2 | Product used for unknown indication |
| 126578621 | 12657862 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126578621 | 12657862 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126578621 | 12657862 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |